| Product Code: ETC10602415 | Publication Date: Apr 2025 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
The import shipments of human papilloma virus vaccines to Israel in 2024 were predominantly sourced from Switzerland, USA, Germany, China, and Belgium, showcasing a diverse supplier base. Despite a negative Compound Annual Growth Rate (CAGR) from 2020 to 2024, there was a notable growth rate of 8.63% from 2023 to 2024. The Herfindahl-Hirschman Index (HHI) indicated a sustained high concentration within the market in 2024, highlighting the competitive dynamics among the key exporting countries.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Human Papilloma Virus Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Human Papilloma Virus Market Revenues & Volume, 2022 & 2032F |
3.3 Israel Human Papilloma Virus Market - Industry Life Cycle |
3.4 Israel Human Papilloma Virus Market - Porter's Five Forces |
3.5 Israel Human Papilloma Virus Market Revenues & Volume Share, By Virus Type, 2022 & 2032F |
3.6 Israel Human Papilloma Virus Market Revenues & Volume Share, By Vaccine Type, 2022 & 2032F |
3.7 Israel Human Papilloma Virus Market Revenues & Volume Share, By Application Area, 2022 & 2032F |
3.8 Israel Human Papilloma Virus Market Revenues & Volume Share, By Target Population, 2022 & 2032F |
3.9 Israel Human Papilloma Virus Market Revenues & Volume Share, By End Use, 2022 & 2032F |
4 Israel Human Papilloma Virus Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of HPV vaccination in Israel |
4.2.2 Rising incidence of HPV-related cancers in the country |
4.2.3 Government initiatives and programs promoting HPV vaccination |
4.3 Market Restraints |
4.3.1 High cost of HPV vaccines and testing services |
4.3.2 Limited access to healthcare services in certain regions of Israel |
4.3.3 Cultural or religious beliefs impacting the acceptance of HPV vaccination |
5 Israel Human Papilloma Virus Market Trends |
6 Israel Human Papilloma Virus Market, By Types |
6.1 Israel Human Papilloma Virus Market, By Virus Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Human Papilloma Virus Market Revenues & Volume, By Virus Type, 2022 - 2032F |
6.1.3 Israel Human Papilloma Virus Market Revenues & Volume, By HPV 16 & 18, 2022 - 2032F |
6.1.4 Israel Human Papilloma Virus Market Revenues & Volume, By Low-Risk HPV Strains, 2022 - 2032F |
6.2 Israel Human Papilloma Virus Market, By Vaccine Type |
6.2.1 Overview and Analysis |
6.2.2 Israel Human Papilloma Virus Market Revenues & Volume, By Preventative Vaccine, 2022 - 2032F |
6.2.3 Israel Human Papilloma Virus Market Revenues & Volume, By Therapeutic Vaccine, 2022 - 2032F |
6.3 Israel Human Papilloma Virus Market, By Application Area |
6.3.1 Overview and Analysis |
6.3.2 Israel Human Papilloma Virus Market Revenues & Volume, By Preventative Vaccination, 2022 - 2032F |
6.3.3 Israel Human Papilloma Virus Market Revenues & Volume, By Cancer Prevention, 2022 - 2032F |
6.4 Israel Human Papilloma Virus Market, By Target Population |
6.4.1 Overview and Analysis |
6.4.2 Israel Human Papilloma Virus Market Revenues & Volume, By Teenagers, Young Adults, 2022 - 2032F |
6.4.3 Israel Human Papilloma Virus Market Revenues & Volume, By High-Risk Individuals, 2022 - 2032F |
6.5 Israel Human Papilloma Virus Market, By End Use |
6.5.1 Overview and Analysis |
6.5.2 Israel Human Papilloma Virus Market Revenues & Volume, By Cervical Cancer Prevention, 2022 - 2032F |
6.5.3 Israel Human Papilloma Virus Market Revenues & Volume, By Oncology Care, 2022 - 2032F |
7 Israel Human Papilloma Virus Market Import-Export Trade Statistics |
7.1 Israel Human Papilloma Virus Market Export to Major Countries |
7.2 Israel Human Papilloma Virus Market Imports from Major Countries |
8 Israel Human Papilloma Virus Market Key Performance Indicators |
8.1 Rate of HPV vaccination coverage among the target population |
8.2 Number of HPV-related cancer cases diagnosed annually |
8.3 Percentage of healthcare facilities offering HPV vaccination services |
8.4 Public perception and acceptance of HPV vaccination through surveys or polls |
8.5 Investment in research and development for new HPV vaccines and treatments |
9 Israel Human Papilloma Virus Market - Opportunity Assessment |
9.1 Israel Human Papilloma Virus Market Opportunity Assessment, By Virus Type, 2022 & 2032F |
9.2 Israel Human Papilloma Virus Market Opportunity Assessment, By Vaccine Type, 2022 & 2032F |
9.3 Israel Human Papilloma Virus Market Opportunity Assessment, By Application Area, 2022 & 2032F |
9.4 Israel Human Papilloma Virus Market Opportunity Assessment, By Target Population, 2022 & 2032F |
9.5 Israel Human Papilloma Virus Market Opportunity Assessment, By End Use, 2022 & 2032F |
10 Israel Human Papilloma Virus Market - Competitive Landscape |
10.1 Israel Human Papilloma Virus Market Revenue Share, By Companies, 2025 |
10.2 Israel Human Papilloma Virus Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here